Drug Trial News

RSS

Abnormal liver tests in a Mediterranean population

recent population-based study in a small town in Southern Italy found that one in eight residents had abnormal liver tests.

26 Apr 2005

Direct-to-consumer advertising may influence physicians' prescribing decisions

Patients requesting specific medications can have a profound effect on physicians prescribing medications for major depression, according to a new study in the April 27 issue of JAMA.

26 Apr 2005

Revised Bethesda guidelines effective at identifying patients at risk of colorectal cancer

The revised Bethesda guidelines, used for screening patients for a type of hereditary colorectal cancer, are effective for determining which patients should undergo further genetic testing, according to a study in the April 27 issue of JAMA.

26 Apr 2005

Hereditary colorectal cancer risk lowered in those without certain gene defect

Families with a certain type of hereditary colorectal cancer have a reduced cancer risk if they do not have a gene defect found in many with this type of cancer risk, according to a study in the April 27 issue of JAMA.

26 Apr 2005

Pulsating ultrasound enhances gene therapy for tumors

High-intensity focused ultrasound emitted in short pulses is a promising, non-invasive procedure for enhancing gene delivery to cancerous cells without destroying healthy tissue, according to a study in the May issue of the journal Radiology.

26 Apr 2005

Color doppler sonography speeds detection of necrotizing enterocolitis in premature infants

Measuring blood flow to a newborn's intestines using a special form of ultrasound can help radiologists identify a life-threatening complication in a serious bowel disease, according to a study in the May issue of the journal Radiology.

26 Apr 2005

Managed care organizations evaluate trends in epilepsy to provide better care

Computer algorithms were used in a recent study to identify the prevalence and incidence of epilepsy, and epilepsy-related mortality of patients in a managed care organization (MCO).

26 Apr 2005

Genetic screening for iron blood disorder feasible in the workplace

Screening for a condition called haemochromatosis, where iron to builds up in the body, could help prevent organ damage and disease, suggests a study published online today by The Lancet.

26 Apr 2005

Fickle enzyme helps protect, but also can promote heart failure

Enzymes that make the gas nitric oxide (NO) not only protect the heart from damage due to high blood pressure or a heart attack, but also promote heart failure through overgrowth and enlargement of the muscle tissue, say animal researchers at Johns Hopkins.

26 Apr 2005

Despite knowledge, very few follow a healthy lifestyle

New research has shown that despite access to advice on healthy lifestyles and government campaigns to encourage people to adopt a healthier way of life, very few Americans are applying that knowledge to themselves.

25 Apr 2005

Virginity pledges don't reduce teen sexual activity

Adolescents who take public virginity pledges are no less likely to engage in various forms of sexual activity than adolescents who do not take these pledges, a recent study of teen behavior found.

25 Apr 2005

New statin study shows arrested progression of atherosclerosis

The first study to use cutting edge magnetic resonance imaging to examine the effect of a statin - rosuvastatin (Crestor) - on the fatty plaques in arteries, was presented yesterday at the 75th European Atherosclerosis Society Congress. ORION revealed that rosuvastatin has a beneficial effect on the size and composition of fatty plaques in arteries (specifically the carotid artery in the neck). Fatty plaques that are vulnerable to sudden rupture can cause heart attacks and strokes without warning.

25 Apr 2005

Substantially more effective therapy than current treatments for Alzheimer's disease

PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine.

25 Apr 2005

Elderly lung cancer patients tolerate combined chemotherapy and radiotherapy with no higher risk of death than younger patients

Lung cancer remains the leading cause of cancer deaths in the U.S., with half of those diagnosed at age 70 years or older. About 20 percent of patients with lung cancer will have small cell lung cancer (SCLC). In the past, SCLC progressed rapidly despite initial chemotherapy sensitivity and few patients survive three years.

25 Apr 2005

Reduction in oxygen levels greater problem as modern aeroplanes cruise to higher altitudes

More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.

25 Apr 2005

Significant fall in serious violence in England and Wales

There has been a significant fall in serious violence in England (13%) and Wales (20%) over the last five years, according to a major study into trends in serious violence by Cardiff University.

25 Apr 2005

Few US adults report having a healthy lifestyle

Despite clear evidence of the health benefits, few U.S. adults conform to four common healthy behaviors that together characterize a healthy lifestyle, according to the April 25 issue of Archives of Internal Medicine.

25 Apr 2005

Chest x-rays may provide information to help detect osteoporosis in the elderly

Undetected osteoporosis in the elderly might be discovered if chest radiographs (x-ray images) that are done for other reasons were examined for fractures of the vertebrae, according to an article in the April 25 issue of Archives of Internal Medicine.

25 Apr 2005

High risk of second cancers in survivors of childhood soft tissue sarcomas

Children treated for soft tissue sarcomas have a significantly higher risk of developing subsequent cancers later in life, according to a new study. The study appears in the June 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society, and indicates children treated with combined chemotherapy and radiation therapy, in particular, had greater risks of developing a new malignancy.

25 Apr 2005

Viramidine demonstrates anti-HCV Genotype 1 activity that compares favorably to Ribavirin

Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).

23 Apr 2005